Simcha Therapeutics initiates two clinical studies to evaluate ST-067, a decoy-resistant IL-18, in acute myeloid leukemia/myelodysplastic syndrome and multiple myeloma.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.